Pharma Pulse 4/7/25: Advancements for Future Pandemic Preparedness and Supply Chain Stability, Microbial Preservation Supports Quality and Safety in Compounding Pharmacies & more
The latest news for pharma industry insiders.
Crucial Technological Advancements for Future Pandemic Preparedness and Supply Chain Stability
Marcel Botha, CEO of 10XBeta, identifies the most significant technological innovations in medical device manufacturing that will be crucial for future pandemic preparedness and supply chain stability.
How Microbial Preservation Supports Quality and Safety in Compounding Pharmacies
Mark Mulvahill, MBA, MSc, discusses the importance of microbial preservation and reference materials in pharmaceutical manufacturing and compounding pharmacies, highlighting their role in contamination control, regulatory compliance, and enhancing microbiological testing reliability.
Indian Stocks Slump as Trump’s Pharma Comments Trigger Caution
Indian shares tumbled after President Donald Trump’s comments that the US is still considering tariffs on pharmaceutical products.
Viz.ai Wins 2025 Edison Award for Machine Learning Innovation for the Third Consecutive Year
Viz.ai announced that it has been named an Award Winner in the 2025 Edison Awards, for the third year in a row. Viz HCM, the company’s AI software solution designed to detect and triage patients with signs of hypertrophic cardiomyopathy, was recognized in the Health Medical & Biotech category and Cardiovascular Health Diagnostics and Monitoring subcategory. The Edison Awards, named after the American inventor Thomas Alva Edison, honor excellence in new product and service development, marketing, design and innovation. The awards are widely recognized as one of the premier accolades that companies can receive in the name of innovation and business success.
‼️ BREAKING ‼️: US President Trump issues new reciprocal tariffs. With manufacturing representing 11% of US gross domestic product, yet accounting for 35% of American productivity growth and 60% of exports, the move, per the president, is meant to encourage domestic production.
Trump's executive order also features a 10% baseline tax, expected to take effect April 9. More on Pharmaceutical Commerce.
Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs
